Cerivastatin sodium is sodium [S-[R*,S*-(E)]]-7-[4-(4-fluorophenyl)-5-methoxymethyl)-2,6bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate.
The empirical formula for cerivastatin sodium is C26H33FNO5Na
and its molecular weight is 481.5. It has the following chemical structure:
Cerivastatin sodium is a white to off-white hygroscopic amorphous powder that is soluble in water, methanol, and ethanol, and very slightly soluble in acetone.
Cerivastatin sodium is an entirely synthetic, enantiomerically pure inhibitor
of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase
catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate-limiting
step in the biosynthesis of cholesterol.
BAYCOL® (cerivastatin sodium tablets) is supplied as tablets containing
0.2, 0.3, 0.4 or 0.8 mg of cerivastatin sodium, for oral administration. Active
Ingredient: cerivastatin sodium. Inactive Ingredients: mannitol, magnesium stearate,
sodium hydroxide, crospovidone, povidone, iron oxide yellow, methylhydroxypropylcellulose,
polyethylene glycol, and titanium dioxide.
Last reviewed on RxList: 4/17/2009
This monograph has been modified to include the generic and brand name in many instances.